Related Experiment Video
Updated: May 1, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Mechanistic insights and characterization of sickle cell disease-associated cardiomyopathy
Ankit A Desai1, Amit R Patel2, Homaa Ahmad3
1Department of Medicine, University of Illinois Hospitals and Health Sciences System, Chicago, IL.
Insights
Sickle cell cardiomyopathy involves heart chamber dilation and fibrosis, linked to transfusions. Diastolic dysfunction is associated with aortic stiffness in sickle cell disease patients.
Area of Science:
- Cardiology
- Hematology
- Medical Imaging
Background:
- Cardiovascular disease is a major cause of death in sickle cell disease (SCD).
- Sickle cell cardiomyopathy requires detailed characterization to understand its mechanisms.
Purpose of the Study:
- To characterize sickle cell cardiomyopathy using advanced noninvasive cardiovascular imaging.
- To identify potential mechanisms causing cardiac dysfunction in SCD.
Main Methods:
- Multimodality cardiovascular testing including MRI, echocardiography, and tonometry.
- Comparison of 38 adults with SCD and 13 healthy controls.
Main Results:
- Patients with SCD showed significant dilation of all four heart chambers compared to controls.
- Reduced myocardial perfusion reserve and diastolic dysfunction were observed in SCD patients.
- Left ventricular dilation and fibrosis correlated with hepatic iron overload, while diastolic dysfunction correlated with aortic stiffness.
Conclusions:
- Sickle cell cardiomyopathy presents with chamber dilation, fibrosis, abnormal perfusion, and diastolic dysfunction.
- Cardiac abnormalities are linked to transfusion history and aortic stiffness in SCD.
Background:
Cardiovascular disease is an important cause of morbidity and mortality in sickle cell disease (SCD). We sought to characterize sickle cell cardiomyopathy using multimodality noninvasive cardiovascular testing and identify potential causative mechanisms.
Methods And Results:
Stable adults with SCD (n=38) and healthy controls (n=13) prospectively underwent same day multiparametric cardiovascular magnetic resonance (cine, T2* iron, vasodilator first pass myocardial perfusion, and late gadolinium enhancement imaging), transthoracic echocardiography, and applanation tonometry. Compared with controls, patients with SCD had severe dilation of the left ventricle (124±27 vs 79±12 mL/m(2)), right ventricle (127±28 vs 83±14 mL/m(2)), left atrium (65±16 vs 41±9 mL/m(2)), and right atrium (78±17 vs 56±17 mL/m(2); P<0.01 for all). Patients with SCD also had a 21% lower myocardial perfusion reserve index than control subjects (1.47±0.34 vs 1.87±0.37; P=0.034). A significant subset of patients with SCD (25%) had evidence of late gadolinium enhancement, whereas only 1 patient had evidence of myocardial iron overload. Diastolic dysfunction was present in 26% of patients with SCD compared with 8% in controls. Estimated filling pressures (E/e', 9.3±2.7 vs 7.3±2.0; P=0.0288) were higher in patients with SCD. Left ventricular dilation and the presence of late gadolinium enhancement were inversely correlated to hepatic T2* times (ie, hepatic iron overload because of frequent blood transfusions; P<0.05 for both), whereas diastolic dysfunction and increased filling pressures were correlated to aortic stiffness (augmentation pressure and index, P<0.05 for all).
Conclusions:
Sickle cell cardiomyopathy is characterized by 4-chamber dilation and in some patients myocardial fibrosis, abnormal perfusion reserve, diastolic dysfunction, and only rarely myocardial iron overload. Left ventricular dilation and myocardial fibrosis are associated with increased blood transfusion requirements, whereas left ventricular diastolic dysfunction is predominantly correlated with increased aortic stiffness.
Clinical Trial Registration Url:
http://www.clinicaltrials.gov. Unique identifier: NCT01044901.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Multiple Allele Traits
Myocarditis I: Introduction

